Intus Care
$20.0K
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Intus Care is currently valued at N/A as of May 2, 2025. The company has raised a total of $31.0M in funding.
Investment Perspective
Intus Care's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Intus Care Worth in 2025?
As of 2025, Intus Care is valued at N/A, based on the company's Later Stage VC funding round in May 2, 2025. This valuation positions Intus Care as one of the leading private companies in the sector.
Intus Care Valuation History
Intus Care's funding history demonstrates steady growth and investor confidence.
How Intus Care Valuation is Determined
Private company valuations like Intus Care's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Intus Care Valuation FAQs
Is Intus Care profitable?
Intus Care has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Intus Care's valuation compare to competitors?
Intus Care is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Intus Care IPO?
Intus Care has not announced plans for an initial public offering. Until an IPO, investors can access Intus Care shares through secondary market platforms.